Scrip is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Patheon opens new US headquarters

This article was originally published in Scrip

Executive Summary

Patheon has opened its new US headquarters and pharmaceutical development laboratory in the vicinity of Research Triangle Park, North Carolina. The pharmaceutical facility will support the firm's current US-based pharmaceutical development operations in Cincinnati and will initially offer stability studies, validation testing and analytical chemistry services. The move means that Patheon joins more than 170 other companies currently headquartered in the region, which was established nearly five decades ago. Earlier this week, Patheon said that it received a buyout offer from the private equity firm JLL, valuing Patheon at Cdn$229 million ($183.3 million). Patheon has yet to comment on the bid but "remains very confident in its business plan and continues to run the business as usual".




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts